Rite Aid Corp (RAD)
$7.51
0.00 (0.00%)
RAD Stock Quote Delayed 15 Minutes
Previous Close
$7.51
Market Cap
8.01B
PE Ratio
-22.09
EPS
-0.34
Volume (Avg. Vol.)
Day's Range
7.51 - 7.51
52-Week Range
0.43 - 11.37
Dividend & Yield
N/A (N/A)
RAD Stock Predictions, Articles, and Rite Aid Corp News
For Rite Aid Stock, Everything Depends on Millennials
As with most investments, the future of Rite Aid stock depends on millennials. Here, new Rite Aid CEO Heyward Donigan has both an opportunity as well as significant risks.
Even After Recent Gains Rite Aid Stock Is Still Underweight
Despite its cheap price, Rite Aid stock is hardly what you would call a discount. Instead, it’s a junk equity that you should steer clear from, considering that it doesn’t have an Amazon Counter-like catalyst in the foreseeable future.
It’s Still Too Risky to Bet on Rite Aid Stock
RAD stock is coming off of its best seven-day stretch in five years, but this rally may mean nothing in Rite Aid's bigger picture.
With 3 New Growth Catalysts, Is Rite Aid Stock Finally a Buy?
RAD stock has been in an awful downtrend... for 15 years. But there's still some value and opportunity here.
Is Rite Aid Stock the Best Play Under $6?
Having been gutted in the markets over the years, Rite Aid stock appeals to risk-tolerant contrarians. However, there are other names with similar upside potential but with much more stable fundamentals.
Rite Aid Stock Is Risky but Could Pay Off
Rite Aid stock is not for the faint of heart, but RAD stock could surprise the critics and enrich the intrepid.
Rite Aid Stock Continues to Fade into Irrelevance Despite Amazon
The Amazon deal with Rite Aid has only made RAD stock temporarily interesting. But to sustain momentum, the pharmacy needs a much deeper partnership with the e-commerce giant.
Don’t Count on Amazon to Save Rite Aid Stock Just Yet
A unique Amazon partnership provides a glimmer of hope for RAD stock, but don't bet on that glimmer of hope until it gets brighter.
New Rite Aid CEO Needs More Than Amazon Partnership to Drive RAD Stock Higher
Heyward Donigan isn't the reason RAD stock has tanked of late. But, if she doesn't appreciate where Rite Aid is wasting money, she may be the reason Rite Aid stock continues to lose ground.
Think Amazon Will Save Rite Aid Stock? Think Again.
A package pick-up service sounds promising for Rite Aid, but just like the RAD stock price chart, it’s an uphill battle.
Maybe Amazon Will Wake up Rite Aid Stock, but It’s a Risky Bet
The Amazon catalyst gives RAD stock unique breakout potential from today's depressed levels, but that potential is accompanied by ample risk.
Take a Deeper Look at Rite Aid Stock and the Amazon Deal
Fundamentally, speculators in Rite Aid stock are ignoring the demographic tailwind that the retail pharmacy’s deal with Amazon provides.
Investors Shouldn’t Gamble on Rite Aid Stock
Rite Aid’s partnership with Amazon might have put some life in the RAD stock price, but Rite Aid stock is still nothing but cheap trash.
The Worst Appears to Be Over for CVS Stock
Over the years, CVS stock has incurred some painful losses in the markets. However, bold moves by management make this a compelling contrarian buy.
5 Top Stock Trades for Friday: IQ, RAD, KBH, PIR
Rite Aid, iQiyi, KB Home, Pier 1 and ConAgra are all on the move Thursday. Here are our top stock trades as a result.
It’s a Little Dicey, but CVS Stock Actually Might Have Turned the Corner
CVS stock has been bleeding for four years. Now, the light at the end of the tunnel is here for CVS Health.
3 Big Stock Charts for Tuesday: Marathon Oil, Fifth Third Bancorp and IHS Markit
The stock charts of FITB, MRO and INFO stock are on the verge of major moves. Here's what to look for today.
There’s a Buy the Dip Opportunity in Walgreens Stock but It Isn’t Now
Walgreens stock tanked after the company reported weak second-quarter results and issued a light outlook, but there's opportunity here.
5 Top Stock Trades for Friday: CGC, CVS, ICPT, RAD, UNH
Canopy Growth, CVS Health, Intercept Pharmaceuticals, Rite Aid and UnitedHealth are our top stock trades to watch for Friday.
Navellier Ratings
Powered by Portfolio GraderTotal Grade
D
10 Stocks Set for Monster Growth
He found Apple at $4… Oracle at $6… Amazon at $40… Now legendary growth investor Louis Navellier is giving away his latest Research Report — for FREE!
Download your FREE COPY!
